We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-6.62%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$159M
AUM Growth
-$13M
Cap. Flow
-$34.8K
Cap. Flow %
-0.02%
Top 10 Hldgs %
22.04%
Holding
189
New
40
Increased
46
Reduced
55
Closed
32

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$1.24M
2
ARW icon
Arrow Electronics
ARW
+$1.12M
3
IDXX icon
Idexx Laboratories
IDXX
+$918K
4
ROL icon
Rollins
ROL
+$908K
5
DHR icon
Danaher
DHR
+$906K

Top Sells

Rank Stock Value
1
LNG icon
Cheniere Energy
LNG
+$2.66M
2
WMT icon
Walmart Inc
WMT
+$2.1M
3
CHRW icon
C.H. Robinson
CHRW
+$1.39M
4
ABT icon
Abbott
ABT
+$1.31M
5
AME icon
Ametek
AME
+$1.26M

Sector Composition

Rank Sector Weight
1 Industrials 21.35%
2 Healthcare 19.44%
3 Financials 12.65%
4 Consumer Staples 12.28%
5 Technology 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$618B
$4.82M 3.04%
29,532
+2,275
+8% +$385K
CHD icon
2
Church & Dwight Co
CHD
$23.4B
$4.29M 2.71%
60,100
– –
MSFT icon
3
Microsoft
MSFT
$3.45T
$4.11M 2.59%
17,641
+2,110
+14% +$557K
AAPL icon
4
Apple
AAPL
$4.54T
$3.99M 2.51%
28,866
-1,226
-4% -$192K
KO icon
5
Coca-Cola
KO
$377B
$3.35M 2.11%
59,838
+13,150
+28% +$817K
PFE icon
6
Pfizer
PFE
$143B
$3.24M 2.04%
74,118
-344
-0.5% -$16.7K
CSX icon
7
CSX Corp
CSX
$93.4B
$2.83M 1.78%
106,244
-1,200
-1% -$37.3K
CSCO icon
8
Cisco
CSCO
$457B
$2.81M 1.77%
70,238
+11,070
+19% +$491K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.36T
$2.78M 1.75%
29,085
+4,845
+20% +$537K
KMB icon
10
Kimberly-Clark
KMB
$36.3B
$2.75M 1.73%
24,413
+3,550
+17% +$462K
MRK icon
11
Merck
MRK
$322B
$2.7M 1.7%
31,359
+1,925
+7% +$172K
UNP icon
12
Union Pacific
UNP
$174B
$2.63M 1.66%
13,511
+1,420
+12% +$314K
UPS icon
13
United Parcel Service
UPS
$88.6B
$2.6M 1.63%
16,062
-805
-5% -$152K
ZTS icon
14
Zoetis
ZTS
$32.4B
$2.55M 1.61%
17,203
+1,200
+7% +$201K
URI icon
15
United Rentals
URI
$67.2B
$2.53M 1.59%
9,361
-321
-3% -$93.4K
BMY icon
16
Bristol-Myers Squibb
BMY
$133B
$2.51M 1.58%
35,347
+10,715
+44% +$777K
ELV icon
17
Elevance Health
ELV
$81.5B
$2.47M 1.56%
5,440
+925
+20% +$443K
BRK.B icon
18
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.31M 1.46%
8,666
-350
-4% -$99.6K
HON icon
19
Honeywell
HON
$77B
$2.27M 1.43%
14,418
+449
+3% +$78.2K
TFC icon
20
Truist Financial
TFC
$63.3B
$2.21M 1.39%
50,640
+780
+2% +$37.5K
ABT icon
21
Abbott
ABT
$183B
$2.08M 1.31%
21,544
-12,324
-36% -$1.31M
WASH icon
22
Washington Trust Bancorp
WASH
$743M
$2.02M 1.27%
43,454
+400
+0.9% +$20.4K
DE icon
23
Deere & Co
DE
$160B
$1.86M 1.17%
5,560
+25
+0.5% +$8.56K
PRU icon
24
Prudential Financial
PRU
$42.4B
$1.84M 1.16%
21,461
+1,330
+7% +$128K
XOM icon
25
ExxonMobil
XOM
$644B
$1.73M 1.09%
19,825
– –
1
2 3 4 5

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return

New England Research & Management's Q3 2022 Portfolio in Review

As of Q3 2022, New England Research & Management held 189 positions worth $159M, down 7.6% from $172M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q3 2022 filing shows 40 new, 46 increased, 55 reduced and 32 closed positions. Its largest new stake was United Therapeutics: 5,550 shares worth $1.16M. The largest sale was Cheniere Energy, an estimated $2.66M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q3 2022 buy was United Therapeutics: 5,550 shares worth $1.16M.
  • New England Research & Management added most to Coca-Cola in Q3 2022, an estimated $817K increase.
  • New England Research & Management's biggest Q3 2022 reduction was Walmart Inc, cutting an estimated $2.1M.
  • New England Research & Management fully exited Cheniere Energy in Q3 2022, selling an estimated $2.66M.
  • New England Research & Management's ten largest holdings make up 22% of its $159M portfolio in Q3 2022.
  • New England Research & Management opened 40 new positions and closed 32 in Q3 2022.
  • New England Research & Management's portfolio value fell 7.6% quarter-over-quarter to $159M.

Based on New England Research & Management's 13F filing for Q3 2022, filed 6 Oct 2022.